Buy & Sell Suncor Energy Inc. (SU) – Suncor Energy Inc. Price Today
Aura AI Summary
Key Stats
- $79.72BMarket Cap
- EnergySector
- -8.51%3M Drawdown
- $88.10BEnterprise Value
- 2.62%Dividend Yield
- 50 daysTypical Hold Time
Suncor Energy Inc. (SU) is currently valued at a market capitalization of $79.72B, with an enterprise value of $88.10B. Over the past 52 weeks, Suncor Energy Inc. has traded between a low of $35.33 and a high of $69.73, highlighting its annual price range. Over the past three months, Suncor Energy Inc. has recorded a drawdown of -8.51%, reflecting recent price volatility. Suncor Energy Inc. offers a dividend yield of 2.62%, with the most recent dividend of $0.60 paid on 04 Mar 26. On average, investors hold Suncor Energy Inc. for approximately 50 days, indicating typical investor behavior on the platform.
About Suncor Energy Inc.
Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Most Recent News
CBAK Energy unveils advanced LFP cylindrical batteries boosting Southeast Asia's electric mobility.
CBAK Energy Technology showcased its innovative lithium-ion and sodium-ion cylindrical batteries designed for Southeast Asia's electric two- and three-wheelers at Autotech & Accessories 2026. Their batteries feature long life, high reliability, and s...

WeRide and Renault deploy autonomous Robobus at Roland-Garros for third year, expanding night service.
WeRide and Renault Group continue their partnership by operating the autonomous Robobus shuttle service at the Roland-Garros tennis tournament for the third consecutive year. The service runs a 2.8 km route connecting key points around the stadium, o...

Eli Lilly's gene therapy VERVE-102 cuts LDL cholesterol by up to 62% with lasting effects.
Eli Lilly reported positive Phase 1b results for VERVE-102, a gene therapy that permanently silences the PCSK9 gene to reduce LDL cholesterol by up to 62%. The therapy showed sustained effects for up to 18 months and was well-tolerated with no seriou...
